Kitano Yutaka | Daiichi Pharmaceutical Co. Ltd. New Product Research Laboratories Ii
スポンサーリンク
概要
- KITANO Yutakaの詳細を見る
- 同名の論文著者
- Daiichi Pharmaceutical Co. Ltd. New Product Research Laboratories Iiの論文著者
関連著者
-
KITANO Yutaka
New Product Research Laboratories II, Daiichi Pharmaceutical Co., Ltd.
-
Kitano Yutaka
Daiichi Pharmaceutical Co. Ltd. New Product Research Laboratories Ii
-
Takasuna Kiyoshi
Drug Safety Research Laboratories Daiichi Pharmaceutical Co. Ltd.
-
KASAI Yoshio
New Product Research Laboratories II, Daiichi Pharmaceutical Co., Ltd.
-
Kasai Yoshio
Drug Safety Research Center Developmental Research Lavoratories
-
Kasai Yoshio
New Product Research Laboratories Ii Daiichi Pharmaceutical Co. Ltd.
-
Kitano Yutaka
Drug Safety Research Laboratories, Daiichi Pharmaceutical Co., LTD.
-
Nomura Mamoru
Drug Safety Research Laboratory Daiichi Pharmaceutical Co. Ltd.
-
Nomura Mamoru
Drug Safety Research Laboratories Daiichi Pharmaceutical Co. Ltd.
-
Nomura Mamoru
Drug Safety Research Center Daiichi Pharmaceutical Co. Ltd.
-
Komiyama Chika
Daiichi Pharmaceutical Co. Ltd. New Product Research Laboratories Ii
-
Komiyama Chika
New Product Research Laboratories Ii Daiichi Pharmaceutical Co. Ltd.
-
Takasawa Akira
Department Of Psychiatry Saitama Medical School
-
Takazawa Akira
Department Of Neuropsychiatry Saitama Medical School
-
HIROHASHI Masaaki
Drug Safety Research Center, Developmental Research Lavoratories, Daiichi Pharmaceutical Co., Ltd.
-
Hirohashi Masaaki
Drug Safety Research Center Developmental Research Lavoratories Daiichi Pharmaceutical Co. Ltd.
-
Nomura Mamoru
Drug Safety Research Cehter Developmental Research Lab. Daiichi Pharmaceutical Co. Ltd.
-
SAKURADA Shinobu
Department of Pharmacology, Tohoku College of Pharmacy
-
Sakurada Shinobu
Department Of Pharmacology Tohoku Pharmaceutical University
-
Sakurada Shinobu
Department Of Physiology And Anatomy Tohoku Pharmaceutical University
-
TAKAZAWA Akira
Department of Physics, Faculty of Science, Science University of Tokyo
-
KOMIYAMA Chika
New Product Research Laboratories II, Daiichi Pharmaceutical Co., Ltd.
-
MAKINO Mitsuhiro
New Product Research Laboratories II, Daiichi Pharmaceutical Co., Ltd.
-
TAKASUNA Kiyoshi
New Product Research Laboratories II, Daiichi Pharmaceutical Co., Ltd.
-
KINOSHITA Masakazu
Department of Neuropsychiatry, Saitama Medical School
-
Mori Kazuhiko
Drug Safety Research Center Developmental Research Lavoratories Daiichi Pharmaceutical Co. Ltd.
-
Yamauchi Tishio
Department Of Psychiatry Saitama Medical School
-
Kinoshita Masakazu
Department Of Psychiatry Saitama Medical School
-
Kitano Yutaka
New Product Research Laboratories Ii Daiichi Pharmaceutical Co. Ltd.
-
Takasuna Kiyoshi
New Product Research Laboratories Ii Daiichi Pharmaceutical Co. Ltd.
-
Makino Mitsuhiro
New Product Research Laboratories Ii Daiichi Pharmaceutical Co. Ltd.
-
Takazawa Akira
Department Of Information Sciences Faculty Of Science And Technology Tokyo University Of Science
-
SAKURADA Shinobu
Department of Physiology and Anatomy, Tohoku Pharmaceutical University
-
SAKURADA Shinobu
Department of Chemical Pharmacology Tohoku College of Pharmacy
-
Takayama Satoshi
Drug Safety Research Center Developmental Research Laboratories Daiichi Pharmaceutical Co.ltd.
-
Yamazaki Osamu
Department of Hepato-Biliary-Pancreatic Surgery, OsakaCity University, Graduate School of Medicine
-
YAMAUCHI Toshio
Department of Neuropsychiatry, Saitama Medical School
-
KAMATAKI Tetsuya
Division of Drug Metabolism, Faculty of Pharmaceuti-cal Sciences, Hokkaido University
-
Takayama Satoshi
Drug Safety Research Center Developmental Research Lab. Daiichi Pharmaceutical Co. Ltd.
-
Kamataki Tetsuya
Division Of Drug Metabolism Faculty Of Pharmaceutical Sciences Hokkaido University
-
Kamataki Tetsuya
Division Of Analytical Biochemistry Faculty Of Pharmaceutical Sciences Hokkaido University
-
Yamazaki Osamu
Department Of Ecological Engineering Toyohashi University Of Technology
-
Yamauchi Toshio
Department Of Neuropsychiatry Saitama Medical School
-
Nishiya Takayoshi
Drug Safety Research Laboratories, Daiichi Pharmaceutical Co., LTD.
-
Hagiwara Miyoko
Drug Safety Research Laboratories, Daiichi Pharmaceutical Co., LTD.
-
KOBAYASHI Reiko
Drug Safety Research Center, Developmental Research Lavoratories, Daiichi Pharmaceutical Co., Ltd.
-
HAGIWARA Takehiro
Drug Safety Research Center, Developmental Research Lavoratories, Daiichi Pharmaceutical Co., Ltd.
-
KAKIHATA Kohji
Drug Safety Research Center, Developmental Research Lavoratories, Daiichi Pharmaceutical Co., Ltd.
-
NAGAI Eiichi
Medical Product Management and Market Planning, Daiichi Pharmaceutical Co., Ltd.
-
USUI Chiharu
Drug Safety Research Center, Developmental Research Laboratories, Daiichi Pharmaceutical Co., Ltd.
-
Kakihata Kohji
Drug Safety Research Center Developmental Research Lavoratories Daiichi Pharmaceutical Co. Ltd.
-
Usui Chiharu
Drug Safety Research Center Developmental Research Laboratories Daiichi Pharmaceutical Co. Ltd.
-
HAGIWARA Takehiro
New Product Research Laboratories II, Daiichi Pharmaceutical Co., Ltd.
-
Hagiwara Miyoko
Drug Safety Research Laboratories Daiichi Pharmaceutical Co. Ltd.
-
Hagiwara Takehiro
New Product Research Laboratories Ii Daiichi Pharmaceutical Co. Ltd.
-
Nishiya Takayoshi
Drug Safety Research Laboratories Daiichi Pharmaceutical Co. Ltd.
-
Kobayashi Reiko
Drug Safety Research Center Developmental Research Lavoratories Daiichi Pharmaceutical Co. Ltd.
-
Yamazaki Osamu
Department Of Neuropsychiatry Saitama Medical School
-
Yamazaki Osamu
Department Of Chemistry Faculty Of Science Chiba University
-
Takayama Satoshi
Drug Safety Research Center Daiichi Pharmaceutical Co. Ltd.
-
Takasawa Akira
Department of Neuropsychiatry, Saitama Medical School
-
Yamauchi Tishio
Department of Neuropsychiatry, Saitama Medical School
著作論文
- Effects of Nefiracetam, a Novel Pyrrolidone-type Nootropic Agent, on the Amygdala-kindled Seizures in Rats
- Anticonvulsant Properties of the Novel Nootropic Agent Nefiracetam in Seizure Models of Mice and Rats
- III G2 The interaction of an opioid kappa antagonist, nor-binaltrophimine(nor-BNI), with nefiracetam in an increasing-current electroshock seizure test of mice and amygdaloid kindled seizures of rats.
- "P-78 An Electroretinogram (ERG) c-wave Recording Procedure in Rats for Evaluation of Visual Toxicity.
- Protective Effects of Kampo Medicines and Baicalin against Intestinal Toxicity of a New Anticancer Camptothecin Derivative, Irinotecan Hydrochloride (CPT-11), in Rats
- Difference in cardiovascular responses to drug between conscious and anesthetized animals.
- 106 STUDY ON ACUTE DIARRHEA INDUCED BY- CPT-11, A NEW ANTI-CANCER DRUG, IN RATS.